FIELD: biotechnology. SUBSTANCE: method involves bacterial mass disruption of producer Pseudomonas putida 84 containing recombinant plasmid pVG-3. Fractionation in lysate buffer is carried out at pH 4.5-5, and concentration and diafiltration - through filter casette type PTGC at limit 10000 dalton. Chromatography is performed on cellulose DE-52 using 0.04-0.06M acetate buffer (pH 4.8-5.2) for elution, then on cellulose CM-52 using linear gradient of 0.1M acetate buffer and 0.1M acetate buffer with 0.3-0.5M sodium chloride (pH 4.8-5.2), and gel-filtration on Sephadex G-100 equilibrated with 0.05-0.15M phosphate buffer with 0.15-0.25M sodium chloride (pH 7.15-7.25). EFFECT: increased purification degree, decreased cost of the end product.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING RECOMBINANT INTERFERON ALPHA-2b AND INTERFERON-CONTAINING PREPARATION (VARIANTS) | 2005 |
|
RU2294372C1 |
SOLUTION FOR INJECTION, RECOMBINANT PLASMID DNA pSX50 ENCODING SYNTHESIS OF HUMAN RECOMBINANT ALPHA-2b INTERFERON, STRAIN Escherichia coli SX50 AS INDUSTRIAL STRAIN-PRODUCER OF HUMAN RECOMBINANT ALPHA-2b INTERFERON AND METHOD FOR INDUSTRIAL PREPARING INTERFERON ALPHA-2b | 2006 |
|
RU2319502C1 |
METHOD OF PREPARATION OF RECOMBINANT ANTAGONIST OF HUMAN INTERLEUKINE-1 RECEPTOR "ARIL" | 2004 |
|
RU2326947C2 |
METHOD OF OBTAINING PEROXYDASE ENZYME FROM HORSE RADISH ROOTS | 2007 |
|
RU2353652C1 |
METHOD FOR PREPARING BETA-D-GALACTOZIDASE | 0 |
|
SU1082812A1 |
METHOD FOR PREPARING RECOMBINANT HUMAN ALPHA-2B-INTERFERON, RECOMBINANT PLASMID AND STRAIN-PRODUCER FOR ITS REALIZATION | 2003 |
|
RU2242516C1 |
RECOMBINANT PLASMID DNA PSS5 ENCODING SYNTHESIS OF RECOMBINANT HUMAN ALPHA-2B INTERFERON, STRAIN OF ESCHERICHIA COLI SS5 AS PRODUCER OF RECOMBINANT HUMAN ALPHA-2B INTERFERON AND METHOD OF ALPHA-2B INTERFERON PREPARING | 1999 |
|
RU2165455C1 |
METHOD OF PRODUCING RECOMBINANT PROTEIN, MODIFIED THROUGH ATTACHMENT OF HUMAN ALBUMIN FROM YEAST CULTURE FLUID | 2007 |
|
RU2373286C2 |
METHOD FOR MAKING RECOMBINANT HUMAN ALPHA 16-INTERFERON AND PHARMACEUTICAL COMPOSITION FOR TREATING VIRAL DISEASES BASED ON RECOMBINANT HUMAN ALPHA 16-INTERFERON | 2007 |
|
RU2380405C2 |
TECHNOLOGY OF EXPERIMENTAL SEPARATION OF HUMAN LACTOFERRIN | 2013 |
|
RU2554742C1 |
Authors
Dates
1995-05-27—Published
1989-04-03—Filed